La prise en charge thérapeutique de l’hypertension artérielle pulmonaire par les antagonistes des récepteurs de l’endothéline en 2008
Authors:
- 1 April 2008
- journal article
- review article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 29 (4) , 283-289
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Medical Therapy for Pulmonary Arterial HypertensionChest, 2007
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2002
- RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSIONClinics in Chest Medicine, 2001
- Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of DiseaseAnnals of Internal Medicine, 2000
- RESPIRATORY COMPLICATIONS IN MIXED CONNECTIVE TISSUE DISEASEClinics in Chest Medicine, 1998
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patientsRheumatology, 1996
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- Pulmonary hypertension in the crest syndrome variant of systemic sclerosisArthritis & Rheumatism, 1986